Biotech Review of the Year Issue 13 - out now!

We’re pleased to share the 13th edition of our Biotech Review of the Year, bringing together practical legal, regulatory and commercial insight for the biotech sector. 

From key developments across cell and gene therapies, regulation, competition scrutiny and litigation trends across the UK and Europe, alongside industry perspectives on the evolving role of in house teams, this year’s Review brings together the issues that matter most.

If you want to stay ahead of the key developments shaping biotech, this is essential reading.

👉 Download the full Review now.